Europe Molecular Diagnostics Market (2016-2022)

  • ID: 4091216
  • Report
  • Region: Europe
  • 130 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

In Europe, Advances in Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Advanced diagnostics for Infectious diseases, Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has been stated that arrays and next-gen sequencing are playing an increased role in the level of invasive technology. Also, it is contributing towards the increasing demand for DNA. In Addition, Cambridge Healthtech Institute has designed Inaugural Biomarkers for Immunotherapy. On the other side many health companies are also offering new range of products with molecular technologies. For Example: Siemens Healthcare has also launched its new product with new VERSANT® kPCR Molecular System. This product improves workflow and consolidation and allows multiple assays per sample and run. Recently, Microbix has also launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Germany, UK, France, Russia, Spain and Italy.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Grifols
  • Qiagen N.V
  • Roche Diagnostics
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia-Pacific Molecular Diagnostics Market, by Product & Services
1.4.2 Asia-Pacific Molecular Diagnostics Market, by Technology
1.4.3 Asia-Pacific Molecular Diagnostics Market, by Application
1.4.4 Asia-Pacific Molecular Diagnostics Market, by End User
1.4.5 Asia-Pacific Molecular Diagnostics Market, by Country
1.5 Methodology for the research

2. Executive Summary

3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints

4. Asia-Pacific Molecular Diagnostics Market
4.1 Asia-Pacific Molecular Diagnostics Market by Product & Services
4.1.1 Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Asia-Pacific Molecular Diagnostics Instruments Market by Country
4.1.3 Asia-Pacific Molecular Diagnostics Software & Services Market by Country

5. Asia-Pacific Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Asia-Pacific Hybridization Molecular Diagnostics Market by Country
5.1.4 Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Asia-Pacific Microarray Molecular Diagnostics Market by Country
5.1.6 Asia-Pacific Other Technologies Market by Country

6. Asia-Pacific Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Asia-Pacific Oncology Molecular Diagnostics Market by Country
6.1.4 Asia-Pacific Oncology Molecular Diagnostics Market by Type
6.1.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Asia-Pacific Other Cancers Molecular Diagnostics Market by Country
6.1.5 Asia-Pacific Blood Screening Molecular Diagnostics Market by Country
6.1.6 Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Asia-Pacific Microbiology Molecular Diagnostics Market by Country
6.1.8 Asia-Pacific Other Applications Market by Country

7. Asia-Pacific Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Asia-Pacific Molecular Diagnostics Market for Other End Users by Country

8. Asia-Pacific Molecular Diagnostics Market by Country
8.1 Introduction
8.2 China Molecular Diagnostics Market
8.2.1 China Molecular Diagnostics Market by Product & Services
8.2.2 China Molecular Diagnostics Market by Technology
8.2.3 China Molecular Diagnostics Market by Application
8.2.3.1 China Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 China Oncology Molecular Diagnostics Market by Type
8.2.4 China Molecular Diagnostics Market by End User
8.3 Japan Molecular Diagnostics Market
8.3.1 Japan Molecular Diagnostics Market by Product & Services
8.3.2 Japan Molecular Diagnostics Market by Technology
8.3.3 Japan Molecular Diagnostics Market by Application
8.3.3.1 Japan Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Japan Oncology Molecular Diagnostics Market by Type
8.3.4 Japan Molecular Diagnostics Market by End User
8.4 India Molecular Diagnostics Market
8.4.1 India Molecular Diagnostics Market by Product & Services
8.4.2 India Molecular Diagnostics Market by Technology
8.4.3 India Molecular Diagnostics Market by Application
8.4.3.1 India Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 India Oncology Molecular Diagnostics Market by Type
8.4.4 India Molecular Diagnostics Market by End User
8.5 South Korea Molecular Diagnostics Market
8.5.1 South Korea Molecular Diagnostics Market by Product & Services
8.5.2 South Korea Molecular Diagnostics Market by Technology
8.5.3 South Korea Molecular Diagnostics Market by Application
8.5.3.1 South Korea Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 South Korea Oncology Molecular Diagnostics Market by Type
8.5.4 South Korea Molecular Diagnostics Market by End User
8.6 Australia Molecular Diagnostics Market
8.6.1 Australia Molecular Diagnostics Market by Product & Services
8.6.2 Australia Molecular Diagnostics Market by Technology
8.6.3 Australia Molecular Diagnostics Market by Application
8.6.3.1 Australia Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Australia Oncology Molecular Diagnostics Market by Type
8.6.4 Australia Molecular Diagnostics Market by End User
8.7 Singapore Molecular Diagnostics Market
8.7.1 Singapore Molecular Diagnostics Market by Product & Services
8.7.2 Singapore Molecular Diagnostics Market by Technology
8.7.3 Singapore Molecular Diagnostics Market by Application
8.7.3.1 Singapore Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Singapore Oncology Molecular Diagnostics Market by Type
8.7.4 Singapore Molecular Diagnostics Market by End User
8.8 Rest of Asia-Pacific Molecular Diagnostics Market
8.8.1 Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Asia-Pacific Molecular Diagnostics Market by Technology
8.8.3 Rest of Asia-Pacific Molecular Diagnostics Market by Application
8.8.3.1 Rest of Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Asia-Pacific Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Asia-Pacific Molecular Diagnostics Market by End User

9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll